$10.17 -0.20 (-1.93%)
11/27/2009 1:00 PM

Enzon Pharmaceuticals, Inc. (ENZN)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.

Featured Broker Partners